Osimertinib Completed Phase N/A Trials for T790M Positive NSCLC Patients

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03133234Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC